254 related articles for article (PubMed ID: 19048252)
1. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
[TBL] [Abstract][Full Text] [Related]
2. Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.
Ishiyama S; Matsueda S; Jones LA; Efferson C; Celestino J; Schmandt R; Ioannides CG; Tsuda N; Chang DZ
Int J Oncol; 2007 Apr; 30(4):889-98. PubMed ID: 17332928
[TBL] [Abstract][Full Text] [Related]
3. Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.
Mine T; Matsueda S; Gao H; Li Y; Wong KK; Peoples GE; Ferrone S; Ioannides CG
Oncol Rep; 2010 Jun; 23(6):1537-43. PubMed ID: 20428807
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells.
Sharma A; Paranjape AN; Rangarajan A; Dighe RR
Mol Cancer Ther; 2012 Jan; 11(1):77-86. PubMed ID: 22075160
[TBL] [Abstract][Full Text] [Related]
5. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
6. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
[TBL] [Abstract][Full Text] [Related]
7. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
[TBL] [Abstract][Full Text] [Related]
8. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Phillips TM; McBride WH; Pajonk F
J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
[TBL] [Abstract][Full Text] [Related]
9. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.
Shi MF; Jiao J; Lu WG; Ye F; Ma D; Dong QG; Xie X
Cell Mol Life Sci; 2010 Nov; 67(22):3915-25. PubMed ID: 20549538
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
[TBL] [Abstract][Full Text] [Related]
11. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
12. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.
Meng E; Long B; Sullivan P; McClellan S; Finan MA; Reed E; Shevde L; Rocconi RP
Clin Exp Metastasis; 2012 Dec; 29(8):939-48. PubMed ID: 22610780
[TBL] [Abstract][Full Text] [Related]
13. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
[TBL] [Abstract][Full Text] [Related]
15. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
[TBL] [Abstract][Full Text] [Related]
17. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations.
Jin H; Kim HJ
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502547
[TBL] [Abstract][Full Text] [Related]
18. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
[TBL] [Abstract][Full Text] [Related]
19. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.].
Jing H; Liu XY; Chen YL; Bai LP; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):878-882. PubMed ID: 28598117
[TBL] [Abstract][Full Text] [Related]
20. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.
Jiang X; Xing H; Kim TM; Jung Y; Huang W; Yang HW; Song S; Park PJ; Carroll RS; Johnson MD
Stem Cells; 2012 Jul; 30(7):1313-26. PubMed ID: 22553175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
